PDE7B antibody (C-Term)
Quick Overview for PDE7B antibody (C-Term) (ABIN954068)
Target
See all PDE7B AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 424-454, C-Term
-
Specificity
- This antibody recognizes Human PDE7B (C-term).
-
Purification
- Protein A column, followed by peptide affinity purification
-
Immunogen
- KLH conjugated synthetic peptide between 424-454 amino acids from the C-terminal region of Human PDE7B
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- PDE7B (phosphodiesterase 7B (PDE7B))
-
Alternative Name
- PDE7B
-
Background
- The 3',5'-cyclic nucleotides cAMP and cGMP function as second messengers in a wide variety of signal transduction pathways. 3',5'-cyclic nucleotide phosphodiesterases (PDEs) catalyze the hydrolysis of cAMP and cGMP to the corresponding 5'-monophosphates and provide a mechanism to downregulate cAMP and cGMP signaling. This gene encodes a cAMP-specific phosphodiesterase, a member of the cyclic nucleotide phosphodiesterase family.Synonyms: 5'-cyclic phosphodiesterase 7B, MGC88256, Phosphodiesterase 7B, cAMP-specific 3', rolipram-insensitive phosphodiesterase type 7
-
Molecular Weight
- 51835 Da
-
Gene ID
- 27115
-
NCBI Accession
- NP_061818
-
Pathways
- cAMP Metabolic Process
Target
-